Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.

Yao Hao Teo,Yao Neng Teo,Nicholas Syn,Cheryl Shumin Kow,Celine Shuen Yin Yoong,Benjamin Y.Q. Tan,Tiong Cheng Yeo,Chi-Hang Lee,Weiqin Lin,Ching-Hui Sia

Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.

2021

Yao Hao Teo
Yao Neng Teo
Nicholas Syn
Cheryl Shumin Kow
Celine Shuen Yin Yoong
Benjamin Y.Q. Tan
Tiong Cheng Yeo
Chi-Hang Lee
Weiqin Lin
Ching-Hui Sia

Background Recent studies have increasingly shown that sodium‐glucose cotransporter 2 (SGLT2) inhibitors may have beneficial cardiovascular and metabolic effects in patients without diabetes mellit...

Keywords:

metabolic effects
Pharmacology
Meta-analysis
in patient
Sodium/Glucose Cotransporter 2
Medicine
Diabetes mellitus
Cotransporter
Randomized controlled trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations